Strain Summary(C.B-17;ICR-Prkdcscid x C.B-17;ICR)F1-Prkdcscid/+
Strain Name |
(C.B-17;ICR-Prkdcscid x C.B-17;ICR)F1-Prkdcscid/+ |
Strain Type(s) |
other • spontaneous mutation |
Strain Synonym(s) |
F1 • Prkdcscid |
Description |
F1 hybrid were heterozygous for the SCID mutation on a mixed C.B-17, ICR (outbred) background.. |
Strain Genetics |
Prkdcscid / Prkdc+ |
| Frequency | ||||||||
|---|---|---|---|---|---|---|---|---|
| Model Name | Organ Affected | Tumor Inducing Agent(s) | Female | Male | Mixed Pop. | Unspecified | Additional Information | Model Details |
| Adrenal gland adenocarcinoma | Adrenal gland |
9.43 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Adrenal gland adenocarcinoma | Adrenal gland | gamma-radiation |
6.54 - 14.42 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Adrenal gland adenoma | Adrenal gland |
27.36 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Adrenal gland adenoma | Adrenal gland | gamma-radiation |
16.82 - 28.97 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Adrenal gland tumor | Adrenal gland |
0 - 36.79 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Adrenal gland tumor | Adrenal gland | gamma-radiation |
0.96 - 40.19 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Kidney tumor | Kidney |
0.94 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Kidney tumor | Kidney | gamma-radiation |
0 - 2.88 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Leukocyte leukemia | Leukocyte |
0 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Leukocyte leukemia | Leukocyte | gamma-radiation |
0.96 - 1.87 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Leukocyte lymphoma | Thymus | gamma-radiation |
0 - 3.74 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Leukocyte lymphoma | Thymus |
4.72 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Leukocyte lymphoma | Leukocyte |
64.15 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Leukocyte lymphoma | Leukocyte | gamma-radiation |
50.47 - 54.21 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Leukocyte tumor | Leukocyte | gamma-radiation |
0 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Liver hepatocellular adenoma | Liver |
2.83 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Liver hepatocellular adenoma | Liver | gamma-radiation |
5.61 - 17.76 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Liver hepatocellular carcinoma | Liver |
2.83 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Liver hepatocellular carcinoma | Liver | gamma-radiation |
13.08 - 26.92 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Liver tumor | Liver |
5.66 - 8.49 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Liver tumor | Liver | gamma-radiation |
2.88 - 36.54 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Lung adenocarcinoma | Lung |
16.04 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Lung adenocarcinoma | Lung | gamma-radiation |
15.89 - 25 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Lung adenoma | Lung |
20.75 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Lung adenoma | Lung | gamma-radiation |
10.28 - 20.56 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Lung tumor | Lung |
1.89 - 34.91 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Lung tumor | Lung | gamma-radiation |
0 - 34.58 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Mammary gland adenocarcinoma | Mammary gland |
11.32 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Mammary gland adenocarcinoma | Mammary gland | gamma-radiation |
5.61 - 16.82 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Mammary gland adenoma | Mammary gland |
2.83 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Mammary gland adenoma | Mammary gland | gamma-radiation |
0.93 - 0.96 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Mammary gland tumor | Mammary gland |
4.72 - 12.26 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Mammary gland tumor | Mammary gland | gamma-radiation |
0.93 - 26.17 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
0 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Ovary - Granulosa cell tumor | Ovary - Granulosa cell | gamma-radiation |
28.04 - 44.86 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Ovary adenocarcinoma | Ovary |
0 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Ovary adenocarcinoma | Ovary | gamma-radiation |
1.87 - 4.81 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Ovary adenoma | Ovary |
0 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Ovary adenoma | Ovary | gamma-radiation |
6.54 - 15.38 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Ovary tumor | Ovary |
0.94 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Ovary tumor | Ovary | gamma-radiation |
9.35 - 64.42 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Skin tumor | Skin |
1.89 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Skin tumor | Skin | gamma-radiation |
2.88 - 3.74 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Spleen tumor | Spleen |
7.55 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Spleen tumor | Spleen | gamma-radiation |
6.54 - 11.21 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Uterus adenocarcinoma | Uterus |
0 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Uterus adenocarcinoma | Uterus | gamma-radiation |
0 - 2.88 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Uterus adenoma | Uterus |
5.66 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Uterus adenoma | Uterus | gamma-radiation |
2.8 - 3.85 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Uterus polyp | Uterus |
15.09 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Uterus polyp | Uterus | gamma-radiation |
3.74 - 7.48 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| Uterus tumor | Uterus |
11.32 - 30.19 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| Uterus tumor | Uterus | gamma-radiation |
3.74 - 14.95 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||
| (Unspecified organ) tumor | (Unspecified organ) |
19.81 - 97.17 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
|||||
| (Unspecified organ) tumor | (Unspecified organ) | gamma-radiation |
13.08 - 97.12 |
References: Ishii-Ohba H, Mutat Res 2007 Jun 1;619(1-2):124-33 |
||||